Innate Pharma
IPHA
#8737
Rank
โ‚ฌ0.14 B
Marketcap
1,50ย โ‚ฌ
Share price
-0.97%
Change (1 day)
-7.34%
Change (1 year)

Market capitalization of Innate Pharma (IPHA)

Market cap: โ‚ฌ0.14 Billion

As of January 2026 Innate Pharma has a market cap of โ‚ฌ0.14 Billion. This makes Innate Pharma the world's 8737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Innate Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.14 B2.38%
2025โ‚ฌ0.14 B-15.33%
2024โ‚ฌ0.16 B-19.38%
2023โ‚ฌ0.20 B-25.33%
2022โ‚ฌ0.27 B-21.15%
2021โ‚ฌ0.35 B29.36%
2020โ‚ฌ0.27 B-41.78%
2019โ‚ฌ0.46 B-1.32%
2018โ‚ฌ0.47 B75.35%
2017โ‚ฌ0.27 B-65.69%
2016โ‚ฌ0.79 B8.59%
2015โ‚ฌ0.72 B74.24%
2014โ‚ฌ0.41 B84.47%
2013โ‚ฌ0.22 B175.41%
2012โ‚ฌ82.3 M107.75%
2011โ‚ฌ39.61 M-9.82%
2010โ‚ฌ43.93 M-51.52%
2009โ‚ฌ90.62 M154.49%
2008โ‚ฌ35.6 M-43.41%
2007โ‚ฌ62.92 M-41.87%
2006โ‚ฌ0.10 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Innate Pharma was reported to be:

โ‚ฌ0.13 Billion
by Nasdaq info icon info icon
โ‚ฌ0.14 Billion
by CompaniesMarketCap info icon info icon